Cleveland Clinic Akron General

Summary

Cleveland Clinic Akron General is a medical facility located in Akron, Ohio. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer and other specialties. Cleveland Clinic Akron General is involved with conducting 240 clinical trials across 281 conditions. There are 10 research doctors associated with this hospital, such as Kathryn M. Leininger, Esther H. Rehmus, Judy Peih-Ying Tsai, and Ashok Ramalingam.

Top PIs

Clinical Trials running at Cleveland Clinic Akron General

Prostate Cancer

Breast Cancer

Lung Cancer

Pancreatic Cancer

Ovarian Cancer

Bladder Cancer

Small Cell Lung Cancer

Breast cancer

Colorectal Cancer

Prostate Adenocarcinoma

Shorter vs Usual Radiation Therapy

for Prostate Cancer

This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.

Recruiting

2 awards

Phase 3

10 criteria

Apalutamide + Hormone and Radiation Therapies

for Prostate Cancer

This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.

Recruiting

2 awards

Phase 3

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria